ArticleBMC plant biology2025
Comprehensive analysis of SPL gene family and miR156a/SPLs in the regulation of terpenoid indole alkaloid biosynthesis in Catharanthus roseus L.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integrated Analysis Reveals Functional Ingredients Biosynthesis and Regulatory Mechanisms inFood science & nutrition · 2026Article
- GhmiR156-International journal of molecular sciences · 2025Article
- Metabolic Engineering of Terpenoid Biosynthesis in Medicinal Plants: From Genomic Insights to Biotechnological Applications.Current issues in molecular biology · 2025Review
- Unraveling the multifaceted roles of SPL transcription factors in leaf development.Frontiers in plant science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundCatharanthus roseus (C. roseus), belongs to the dogbane family Apocynaceae, is the source of various terpenoid indole alkaloids (TIAs) with excellent antitumor properties, including vinblastine, vincristine, ajmalicine, serpentine, vindoline, and catharanthine. However, TIAs are widely used in clinical anticancer research, their content is extremely low in plants, and currently insufficient to meet market demand. Therefore, exploring TIAs regulation is essential to improve TIAs yield. Numerous transcription factors have been shown to be involved in vinblastine biosynthesis, while the function of SPL members (CrSPL) has not yet been investigated in C. roseus. SPL genes regulate both plant growth and development as well as metabolite accumulation.
resultsIn this study, genome-wide analysis identified fourteen CrSPL genes. The analysis included their gene structure, phylogenetic relationships, spatio-temporal expression profiles, response to methyl jasmonate and microRNA interactions. The yeast-one-hybrid (Y1H) and Dual-Luciferase (Dual-Luc) assays and transient overexpression show that CrSPLs can directly regulate the vinblastine biosynthesis pathway. The Cro-microRNA member, Cro-miR156a, can efficiently inhibit the activity of CrSPLs members and TIAs pathway genes.
conclusionsCro-miR156a and CrSPLs regulate TIAs biosynthesis, and this study provides a promising reference for investigating the roles of CrSPL TFs in regulating TIAs biosynthesis in C. roseus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.